Dashenlin Pharmaceutical Group Co., Ltd. Class ASSE: 603233

"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Reply to the Inquiry Letter on the Company's 2025 Annual Report

· Issued by Dashenlin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Reply to the Inquiry Letter on the Company's 2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Dashenlin Pharmaceutical Group Co., Ltd. Class A

All Dashenlin Pharmaceutical Group Co., Ltd. Class A news releases